Analystreport

Regeneron Pharmaceuticals (NASDAQ:REGN) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com